Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 13,888 | 15,135 | 18,452 | 16,221 | 16,574 |
| Cost of Goods | 4,702 | 4,881 | 5,646 | 5,435 | 4,589 |
| Gross Profit | 9,186 | 10,254 | 12,806 | 10,786 | 11,985 |
| Operating Expenses | 11,392 | 18,758 | 11,031 | 12,916 | 13,504 |
| Operating Income | -1,504 | -7,623 | 2,421 | -1,695 | -930 |
| Interest Expense | 516 | 730 | 900 | 1,079 | 994 |
| Other Income | 3,985 | -11,090 | 2,297 | 3,156 | 3,422 |
| Pre-tax Income | 1,965 | -19,443 | 3,818 | 382 | 1,498 |
| Income Tax | N/A | 437 | -122 | -283 | 405 |
| Net Income Continuous | 1,965 | -19,880 | 3,940 | 665 | 1,093 |
| Net Income Discontinuous | N/A | 62 | 54 | 123 | 381 |
| Net Income | $1,965 | $-19,818 | $3,994 | $788 | $1,474 |
| EPS Basic Total Ops | 0.21 | -3.18 | 0.65 | 0.13 | 0.24 |
| EPS Basic Continuous Ops | 0.21 | -3.19 | 0.64 | 0.11 | 0.18 |
| EPS Basic Discontinuous Ops | N/A | 0.01 | 0.01 | 0.02 | 0.06 |
| EPS Diluted Total Ops | -0.08 | -1.96 | 0.21 | -0.26 | -0.15 |
| EPS Diluted Continuous Ops | -0.08 | -1.98 | 0.20 | -0.28 | -0.20 |
| EPS Diluted Discontinuous Ops | N/A | 0.04 | 0.01 | 0.01 | 0.04 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.26 | 0.20 | -0.28 | -0.20 |
| EBITDA(a) | $-672 | $-6,303 | $3,765 | $-235 | $431 |